Brochure | May 5, 2026

AbbVie CMO Brochure

Source: AbbVie
cdmo-tech-transfer-GettyImages-2217587867

Integrated pharmaceutical development and manufacturing services support programs from early research through global commercial supply. Capabilities span biologics, small molecules, high‑potency compounds, antibody‑drug conjugates, ophthalmics, oral solid dose products, aseptic fill‑finish, and advanced drug delivery formats, enabling flexible solutions across diverse therapeutic needs.

Development services include cell line and cell bank creation, process and analytical development, formulation science, scale‑up, and extended characterization. Manufacturing operations leverage both single‑use and stainless‑steel technologies across a global network, offering broad capacity ranges and built‑in redundancy to support continuity of supply. Specialized expertise in containment, lyophilization, hot melt extrusion, and complex conjugation addresses challenging molecules and formulations.

Comprehensive quality, regulatory, and analytical support is embedded throughout the lifecycle, reinforcing compliance and execution reliability. Together, these integrated capabilities help reduce risk, simplify technology transfer, and accelerate the path from development milestones to successful commercialization.

access the Brochure!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Outsourced Pharma